相关实验视频
Updated: Jan 10, 2026

Depletion and Reconstitution of Macrophages in Mice
Published on: August 1, 2012
异醇醇酸通过代谢重编程的巨细胞来改善肠道炎症
Ying Wang1,2,3, Weihui Yan1,2,3, Hongxia Zhao1,2,3
1Division of Pediatric Gastroenterology and Nutrition, Xinhua Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
异醇醇酸 (isoalloLCA) 降低了儿科炎性肠病 (IBD) 的炎症. 这种胆汁酸重编程巨细胞,通过增强抗炎作用,为IBD提供潜在的新疗法.
科学领域:
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
- 代谢学 代谢学 代谢学
背景情况:
- 在儿科炎症性肠病 (IBD) 中观察到减少胆汁酸的异醇醇醇酸 (isoalloLCA).
- 在儿科IBD病变发生过程中,isoalloLCA的具体作用尚不清楚.
研究的目的:
- 为了研究在儿科IBD中isoalloLCA的治疗潜力.
- 在IBD模型中阐明isoalloLCA抗炎作用的潜在机制.
主要方法:
- 用IsoalloLCA治疗血液细胞和IBD的实验模型.
- 分析炎症标记物,调控性T细胞转录因子 (例如,Foxp3) 和巨细胞信号通路 (例如,ETS2,HIF1A/PFKFB3).
- 评估巨细胞的代谢重编程,包括氧化酸化 (OXPHOS) 和线粒体反应性氧物种 (mitoROS) 生产.
主要成果:
- 在小儿IBD患者的血细胞中,IsoalloLCA降低了脂聚糖 (LPS) 诱导的瘤亡因子 (TNF).
- 在LPS和硫酸 (DSS) 诱导的IBD模型中,IsoalloLCA缓解了急性肠炎,并在慢性结肠炎模型中证明了有效性.
- 在调节性T细胞中,IsoalloLCA增强了Foxp3表达,并在巨细胞中抑制了ETS2,减轻了骨髓衍生巨细胞 (BMDM) 中LPS诱导的炎症.
- IsoalloLCA促进了OXPHOS并减少了巨细胞的炎症,可能是通过增强米托ROS和抑制ETS2-HIF1A/PFKFB3通路.
结论:
- 在儿科IBD的临床前模型中,IsoalloLCA表现出显著的抗炎和治疗作用.
- 通过isoalloLCA对巨细胞的代谢重编程是其抗炎性质的关键机制.
- 伊索阿洛LCA代表了对儿科IBD的有希望的治疗候选者,针对巨细胞功能和新陈代谢.
更多相关视频
08:58Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
07:46Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation
Published on: April 3, 2017
相关概念视频
Drugs for Treatment of Ulcerative Colitis in IBD
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Drugs for Treatment of Constipation-Predominant IBS
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents